Skip to main content
John Galvin Jr., MD, Oncology, Chicago, IL

JohnPatrickGalvinJr.MD

Oncology • Chicago, IL

Hematologic Oncology

Assistant Professor University of Illinois Cancer Center

Join to view full profile

Dr. Galvin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Galvin's full profile

Already have an account?

  • Office

    840 S Wood St
    Suite 130 CSN
    Chicago, IL 60612

Summary

  • Dr. John Galvin is a hematologist with a specialization in stem-cell transplant and GVHD based in Chicago, IL. Dr. Galvin is affiliated with University of Illinois Cancer Center. Dr. Galvin is also a Senior Medical Director for Graft versus Host Disease for Incyte Pharmaceuticals. He has been in practice 11 years. He also has an affiliation with Northwestern University’s department of Immunology & Microbiology.

Education & Training

  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityFellowship, Hematopoietic Stem Cell Transplant, 2012 - 2013
  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2009 - 2012
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2006 - 2009
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 2006

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2009 - 2026
  • NY State Medical License
    NY State Medical License 2008 - 2010
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Development of a Real Time Pharmacokinetic Testing Method to Allow for Targeted Melphalan Dosing in Multiple Myeloma Patients Undergoing Autologous Transplant
    John P Galvin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Low Pre-Treatment Hemoglobin and Creatinine Clearance Correlate with Worse Overall Survival, Treatment-Related Mortality, and Regimen-Related Toxicities in Patients Un...
    John P Galvin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Disease Progression, Hospital Readmissions, and Clinical Outcomes of Patients with Steroid-Refractory Acute Graft-Versus-Host Disease: A Multicenter Chart Review
    John P Galvin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Searching for lymphoma: An analysis of internet and social network activity and engagement. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Survival Differences Among Patients (pts) with Acute Myeloid Leukemia (AML) Treated with Allogeneic Hematopoietic Cell Transplantation (HCT) Versus Non-HCT Therapies: ... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Use of a Processed Hematopoietic Stem Cell Product (FCRx) in Unmatched Related and Unrelated Donor – Recipient Pairs Is Associated with High Levels of Donor Chimerism ... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • Study Shows Structural Racism Can Result in Poorer Leukemia Outcomes
    Study Shows Structural Racism Can Result in Poorer Leukemia OutcomesMarch 7th, 2022

Professional Memberships

Dr. John Galvin, Dr. John Galvin, MD, Dr. J Galvin, Dr. John Patrick Galvin